Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Pharmedium Services, LLC is recalling 10 syringes of Buffered Lidocaine 2% because stability data does not support the expiry date, posing a risk of loss of potency.
Pharmedium Services, LLC is recalling 210 syringes of Fentanyl Citrate and Bupivacaine HCl because stability data does not support the expiration dates, posing a risk of loss of potency.
Pharmedium Services, LLC is recalling 512 syringes of lidocaine HCl 2% because stability data does not support the expiry date, posing a potential loss of potency.
Pharmedium Services, LLC is recalling 1,478 syringes of ePHEDrine Sulfate because stability data does not support the expiration dates, posing a risk of reduced potency.
PharMEDium is recalling 499 syringes of lidocaine HCl 2% because stability data does not support the expiry date, posing a potential loss of potency.
Pharmedium Services, LLC is recalling 498 syringes of Phenylephrine HCl because stability data does not support the expiry date, posing a risk of loss of potency.
Pharmedium Services, LLC is recalling 53,357 syringes of fentanyl citrate injection because stability data does not support the expiry dates, posing a risk of loss of potency.
Pharmedium Services, LLC is recalling 499 syringes of lidocaine HCl 1% because stability data does not support the expiry date, posing a potential loss of potency.
Pharmedium Services, LLC is recalling 1,623 syringes of remifentanil HCl because stability data does not support the expiration dates, posing a risk of reduced drug potency.
Allergan Sales, LLC is recalling Tazorac (tazarotene) Gel 0.05% because it failed content uniformity specifications. The recall covers 25,247 tubes distributed nationwide.
Pharmedium Services, LLC is recalling specific lots of fentanyl citrate syringes because stability data does not support the expiration dates, posing a risk of reduced potency.
Pharmedium Services, LLC is recalling 3,270 syringes of morphine sulfate due to stability data that does not support the expiry date, posing a potential loss of potency.
Pharmedium Services is recalling 8,955 syringes of fentanyl citrate because stability data does not support the expiration dates, posing a risk of reduced drug potency.
Pharmedium Services, LLC is recalling 830 syringes of lidocaine HCl, 2%, preservative-free, because stability data does not support the expiry dates, posing a risk of potential loss of potency.
Pharmedium Services, LLC is recalling 1,500 syringes of ketamine HCl because stability data does not support the expiration dates, posing a risk of reduced drug potency.
Pharmedium Services, LLC is recalling 16,366 syringes of glycopyrrolate because stability data does not support the expiration dates, posing a risk of reduced drug potency.
Pharmedium Services, LLC is recalling 5,900 syringes of lidocaine HCl 1% because stability data does not support the expiry dates, posing a risk of loss of potency.
Pharmedium Services, LLC is recalling 9,101 syringes of ketamine HCl because stability data does not support the expiration dates, posing a risk of reduced potency.
Pharmedium Services, LLC is recalling specific lots of neostigmine methylsulfate syringes because stability data does not support the expiration dates, posing a risk of reduced potency.
Pharmedium Services, LLC is recalling 2,105 syringes of neostigmine methylsulfate because stability data does not support the expiration dates, posing a risk of reduced potency.
PharMEDium is recalling lidocaine HCl syringes because stability data does not support the expiration dates, posing a risk of reduced drug potency.
Amerisource Health Services is recalling 648 cartons of Paricalcitol Capsules, 1 mcg, due to failed impurities specifications.
Teva Pharmaceuticals USA is recalling MitoXANTRONE Injection USP vials nationwide because they may fail to meet specifications for Impurity D throughout their shelf life.
Dr. Reddy's Laboratories is recalling ZENATANE (isotretinoin) 20 mg capsules because they failed to meet dissolution specifications. The recall covers 3,858 prescription packs distributed nationwide.
The Apothecary Shoppe LLC is recalling Phenotolamine 0.4mg/Prostaglandin 20mcg/mL vials because they were sterilized with a recalled filter, raising concerns about sterility assurance.